Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Tucatinib

Tucatinib synthesis

7synthesis methods
Tukysa (Tucatinib) Tucatinib/Tucatinib (ONT-380) is an oral TKI (tyrosine kinase) inhibitor for the treatment of adult patients with advanced HER2-positive breast cancer. It can be prepared from 1-(4-((4-([ 1 ,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-3- (1-hydroxy-2-methylpropan-2-yl)thiourea in tetrahydrofuran under basic conditions and ptoluenesulfonyl chloride through ring closure reaction.
-

Yield:937263-43-9 96%

Reaction Conditions:

with p-toluenesulfonyl chloride;sodium hydroxide in tetrahydrofuran

Steps:


[001 53j Step 2: 1 -(4-((4-([ 1 ,2,4]Triazolo [1,5 -a]pyridin-7-yloxy)-3 -methylphenyl) amino)quinazolin-6-yl)-3-( 1 -hydroxy-2-methylpropan-2-yl)thiourea was agitated in tetrahydrofuran under basic conditions (2.5N NaOH), followed by the addition ofptoluenesulfonyl chloride. Water was charged to yield N4-(4-([ 1 ,2,4]triazolo [1,5 -a]pyridin-7- yloxy)-3 -methylphenyl)-N6-(4,4-dimethyl-4,5 -dihydrooxazol-2-yl)quinazoline-4,6-diamine (96%) as a mixture of polymorphs (generally a mixture containing one or more of Form C,

References:

ARRAY BIOPHARMA INC.;LEE, Patrice, A.;WINSKI, Shannon, L.;KOCH, Kevin WO2013/142875, 2013, A1 Location in patent:Paragraph 00153

FullText

Tucatinib Related Search: